Cellectar Biosciences, Inc.CLRBNASDAQ

Revenue (LTM)

Net Income (LTM)

$-22M

+51.1% YoY

Free Cash Flow

$-23M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-0
Operating Income	-24	-29↓19.4%	-39↓35.2%	-52↓32.9%	-23↑55.6%
Net Income	-24	-32↓31.8%	-43↓34.5%	-45↓4.2%	-22↑51.1%
EBITDA	-24	-29↓19.5%	-39↓35.2%	-51↓32.8%	-23↑55.8%
EPS Diluted	-130.35	-135.18↓3.7%	-104.99↑22.3%	-41.89↑60.1%	-8.35↑80.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	36	20↓44.4%	10↓51.9%	23↑143.5%	13↓43.3%
Total Current Assets	37	21↓43.9%	10↓49.1%	24↑132.0%	14↓42.1%
Total Assets	37	22↓42.0%	12↓44.1%	25↑111.0%	15↓41.2%
Total Current Liabilities	4	12↑188.2%	25↑120.5%	9↓63.0%	5↓49.4%
Total Liabilities	4	12↑190.0%	26↑114.5%	11↓56.8%	5↓54.7%
Total Equity	33	10↓71.1%	-14↓244.5%	14↑203.8%	10↓30.6%
Total Debt	0	1↑100.1%	1↓8.4%	0↓10.7%	0↓17.1%
Net Debt	-35	-19↑45.6%	-9↑53.2%	-23↓152.9%	-13↑43.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-23	-25↓11.8%	-32↓28.4%	-48↓47.0%	-23↑51.4%
Capital Expenditure	-0	-0↓59.9%	-1↓282.4%	-0↑87.9%	-0↑94.4%
Free Cash Flow	-23	-25↓12.1%	-33↓30.6%	-48↓43.5%	-23↑51.5%
Stock-Based Comp	1	1↑29.2%	2↑65.9%	4↑77.3%	2↓47.0%
Net Change in Cash	-21	-16↑26.2%	-10↑35.0%	14↑233.2%	-10↓173.5%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance